These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A. Lv H, Wang L, Zhang W, Wang Z, Zuo Y, Liu J, Yuan Y. J Neurol Sci; 2015 Nov 15; 358(1-2):153-7. PubMed ID: 26382835 [Abstract] [Full Text] [Related]
24. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease. Sevilla T, Lupo V, Martínez-Rubio D, Sancho P, Sivera R, Chumillas MJ, García-Romero M, Pascual-Pascual SI, Muelas N, Dopazo J, Vílchez JJ, Palau F, Espinós C. Brain; 2016 Jan 15; 139(Pt 1):62-72. PubMed ID: 26497905 [Abstract] [Full Text] [Related]
25. Variability in nerve biopsy findings in a kinship with dominantly inherited Charcot-Marie-Tooth disease. Van Weerden TW, Houthoff HJ, Sie O, Minderhoud JM. Muscle Nerve; 1982 Mar 15; 5(3):185-96. PubMed ID: 7088015 [No Abstract] [Full Text] [Related]
26. [A case of Charcot-Marie-Tooth disease (CMT) type 1 complicated by diabetes mellitus (DM) showing bilateral phrenic nerve palsy]. Takakura Y, Furuya H, Yamashita K, Murai H, Araki T, Kikuchi H, Ohyagi Y, Yamada T, Kira J. Rinsho Shinkeigaku; 2002 Apr 15; 42(4):320-2. PubMed ID: 12561089 [Abstract] [Full Text] [Related]
27. Coexistence of Charcot Marie Tooth disease type 1A and diabetes in Taiwan: A clinicopathological study. Chao HC, Chou CT, Lee YC, Lin KP. J Neurol Sci; 2015 Nov 15; 358(1-2):213-20. PubMed ID: 26349404 [Abstract] [Full Text] [Related]
28. Clinicopathologic analysis of 124 biopsy-proven peripheral nerve diseases. Hong SM, Ha H, Suh JH, Kim KK, Khang SK, Ro JY, Park SH. J Korean Med Sci; 2000 Apr 15; 15(2):211-6. PubMed ID: 10803700 [Abstract] [Full Text] [Related]
29. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination. Sahenk Z. Ann N Y Acad Sci; 1999 Sep 14; 883():415-26. PubMed ID: 10586265 [Abstract] [Full Text] [Related]
30. Ultrastructural and cytochemical observations in a case of dominantly inherited hypertrophic (Charcot-Marie-Tooth) neuropathy. Waxman SG, Ouelette EM. J Neuropathol Exp Neurol; 1979 Nov 14; 38(6):586-95. PubMed ID: 533859 [Abstract] [Full Text] [Related]
37. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Trojaborg W, Hays AP, van den Berg L, Younger DS, Latov N. Muscle Nerve; 1995 Jul 14; 18(7):730-5. PubMed ID: 7540258 [Abstract] [Full Text] [Related]
38. Charcot-Marie-Tooth disease associated with hypertrophic neuropathy: a neuropathologic study of two cases. Smith TW, Bhawan J, Keller RB, DeGirolami U. J Neuropathol Exp Neurol; 1980 Jul 14; 39(4):420-40. PubMed ID: 6260904 [Abstract] [Full Text] [Related]
39. [Clinical phenotype of Charcot-Marie-Tooth disease (CMT) and familial amyloid polyneuropathy (FAP)]. Sobue G. Rinsho Shinkeigaku; 2003 Nov 14; 43(11):769-74. PubMed ID: 15152460 [Abstract] [Full Text] [Related]
40. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Fabrizi GM, Cavallaro T, Angiari C, Bertolasi L, Cabrini I, Ferrarini M, Rizzuto N. Neurology; 2004 Apr 27; 62(8):1429-31. PubMed ID: 15111691 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]